Results 261 to 270 of about 19,068,215 (411)

Not Only Caseload but Also Patient Selection Is Predictive of Mortality After Pancreatic Resection. [PDF]

Ann Surg Open
Mantke R, Seliger B, Ogino S, Büchler MW, Hunger R.   +4 more
europepmc   +1 more source

Patient selection

, 1993
D. Glenn Pennington, David J. Farrar, D Loisance, Walter E. Pae, Robert W. Emery   +4 more
openalex   +1 more source

Can CT Measurement of Emphysema Severity Aid Patient Selection for Lung Volume Reduction Surgery? [PDF]

, 2000
Steve H. Salzman
openalex   +1 more source

Escape from TGF‐β‐induced senescence promotes aggressive hallmarks in epithelial hepatocellular carcinoma cells

Molecular Oncology, EarlyView.
Chronic TGF‐β exposure drives epithelial HCC cells from a senescent state to a TGF‐β resistant mesenchymal phenotype. This transition is characterized by the loss of Smad3‐mediated signaling, escape from senescence, enhanced invasiveness and metastatic potential, and upregulation of key resistance modulators such as MARK1 and GRM8, ultimately promoting
Minenur Kalyoncu, Dilara Demirci, Sude Eris, Bengisu Dayanc, Ece Cakiroglu, Merve Basol, Merve Uysal, Gulcin Cakan‐Akdogan, Fang Liu, Mehmet Ozturk, Gökhan Karakülah, Serif Senturk   +11 more
wiley   +1 more source

Is transcranial colour Duplex flow imaging of use in selection of patients with acute stroke for thrombolysis? [PDF]

, 2000
G. Devuyst
openalex   +1 more source

ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling

Molecular Oncology, EarlyView.
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau, Hayley S. Smith, Begüm Alural, Claire E. Martin, Laura A. New, Manali Tilak, Sara L. Banerjee, Hannah N. Robeson, Nicolas Bisson, Anne‐Claude Gingras, Jasmin Lalonde, Nina Jones   +11 more
wiley   +1 more source

Pembrolizumab for the Treatment of Locally Advanced Cutaneous Squamous Cell Carcinoma: Patient Selection and Special Considerations. [PDF]

Cancer Manag Res
Stewart M, Geiger JL.
europepmc   +1 more source

PATIENT SELECTION FOR ADULT COCHLEAR IMPLANTATION AND ITS EXPERIENCE

, 1993
Mikiko Fukiyama, Koji Matsuura
openalex   +2 more sources

Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project

Prostate Cancer and Prostatic Diseases, 2017
K. Tay, M. Scheltema, H. Ahmed, E. Barret, Jonathan A. Coleman, J. Dominguez-escrig, Sangeet Ghai, Jiaoti Huang, J. Jones, L. Klotz, Cary N. Robertson, R. Sanchez-Salas, S. Scionti, A. Sivaraman, J. Rosette, T. Polascik   +15 more
semanticscholar   +1 more source

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

Molecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit, Thais Pereira‐Veiga, Helena Brauer, Michael Horn, Paula Nissen, Thomas Mair, Bente Siebels, Hannah Voß, Ruimeng Zhuang, Marie‐Therese Haider, Desiree Loreth, Margarita Iskhakova, Bele Lindemann, Julian Kött, Laure Cayrefourcq, Jasmin Wellbrock, Hartmut Schlüter, Klaus Pantel, Catherine Alix‐Panabières, Manfred Jücker   +19 more
wiley   +1 more source